Page 10 - Rapid Detection News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share: Chairman and CEO Alan Jay Weisberg Issues Letter to Shareholders MIAMI, FL, March 03, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Progressive Care Inc. (OTCQB:RXMD) ("Progressive Care," the "Company," "we," "our"), a personalized healthcare services and technology company, issues the following Letter to Shareholders from the Chief Executive Officer: Dear Valued Shareholder, We have completed another impressive year in the history of Progressive Care, Inc. I would like to share with you some of the highlights and accomplishments of the past year, along with a clear picture of where ...

Share this article Share this article FRANKLIN LAKES, N.J., Feb. 22, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Scanwell Health, a leader in smartphone-enabled at-home medical tests, today announced a collaboration to create an at-home rapid test for SARS-CoV-2 using a BD antigen test and the Scanwell Health mobile app. As part of the collaboration, BD plans to produce a lateral flow antigen test and pair it with the Scanwell Health mobile app. The app is expected to provide step-by-step instructions on how to collect...

A peer-reviewed study indicates that the company’s antigen test could be more selective in detecting contagious COVID-19 patients than PCR testing.

COVID Test Results in 15min with New At-Home Test Service from Ready COVID Test Results in 15min with New At-Home Test Service from Ready Ready, an on-demand healthcare service, today announces in-home rapid COVID-19 testing with results in 15 minutes or less. The rapid test can be run from start to finish in the home, increasing the access to widespread testing outside of healthcare facilities. This testing capability not only reduces potential exposure at hospitals or testing sites, but also provides patients with fast and convenient results. Why Readys COVID Test is Different Ready sends...

Taiwan develops microfluidic platform for rapid screening of diseases Taiwan develops microfluidic platform for rapid screening of diseases 18 January 2021 | News Personalized Antibiotic Screening Platform fAST automates both genotype and phenotype detections to identify bacteria within 1.5 hours and finish the multiple antibiotics combination test within 5 hours Photo Credit: PRNewswire Taiwan's Health and Biotech company MedFluid has developed the fastest, first-in-class antimicrobial susceptibility test that will aid in providing precise medical prescriptions to improve the hea...